创新
Search documents
宁高宁:企业家精神就是创新,没有创新我们什么都不是
Xin Lang Cai Jing· 2025-12-08 03:09
专题:2025《中国企业家》影响力企业家年会 第十三届全国政协常委,中国中化控股有限责任公司原党组书记、董事长宁高宁在2025(第二十三届) 影响力企业家年会表示,过去,企业不创新,也能做得很好,今天不一样了,价格战越来越激烈,不创 新能行吗?太卷了,不创新能行吗?投资回报率都在降低,我们很多产品被周边国家逐步替代,不创新 也不行;很多技术需要突破,客户需求在不断变化,不创新更不行。 他表示,现在看起来,创新、研发、技术是我们解决目前所有问题的最好的生产要素,只有创新才有战 略,只有创新才能生存,只有创新才能发展。 新浪声明:所有会议实录均为现场速记整理,未经演讲者审阅,新浪网登载此文出于传递更多信息之目 的,并不意味着赞同其观点或证实其描述。 ""这是我们今天面临的一个问题,也应该形成我们的共识。甚至可以说一句,我们企业的责任、企业家 的精神就是创新,没有创新,我们什么都不是。"他说。 新浪声明:所有会议实录均为现场速记整理,未经演讲者审阅,新浪网登载此文出于传递更多信息之目 的,并不意味着赞同其观点或证实其描述。 责任编辑:李思阳 专题:2025《中国企业家》影响力企业家年会 第十三届全国政协常委,中国中 ...
中国宏观经济展望与数据前瞻-政策支持温和;11 月增长疲软但走势分化-China Economic Comment _ CEWC and data preview_ modest policy support; weak but mixed growth in Nov
2025-12-08 00:41
Summary of Key Points from the Conference Call Industry Overview - The conference call primarily discusses the **Chinese economy** and its macroeconomic policies, particularly in the context of the upcoming **Central Economic Work Conference (CEWC)** scheduled for mid-December 2025. Core Insights and Arguments 1. **Macroeconomic Policy Direction**: - The CEWC will set the macro policy tone for 2026, with expectations for a GDP growth target of **4.5-5%**. The consensus among market participants leans towards "around 5%", which is considered challenging due to slowing exports and a downturn in the property market [2][6][7]. 2. **Fiscal and Monetary Policy**: - A modest support tone in fiscal and monetary policy is anticipated, with a focus on innovation, consumption, and housing market stabilization. The government may confirm the extension of consumption subsidies in 2026 to mitigate disruptions from high base effects [6][8][10]. 3. **Property Market Dynamics**: - The property market is experiencing significant weakness, with **30-city property sales** declining by **-33% YoY** in November, worsening from **-27% YoY** in October. Contract sales from the top 100 developers also fell by **-37% YoY** [3][14][25]. 4. **Investment and Consumption Trends**: - Property investment is expected to contract by **-23% YoY**, while infrastructure investment may see a slight improvement. Retail sales growth is projected to be around **3.2% YoY**, showing some resilience despite the overall economic slowdown [4][31][26]. 5. **High Frequency Data**: - Manufacturing PMIs indicate subdued growth, with the NBS manufacturing PMI at **49.2** and non-manufacturing PMI at **49.5**. This reflects ongoing challenges in the manufacturing sector [12][13]. 6. **Trade and Export Performance**: - Export growth is expected to improve to **2% YoY** on a low base, with port cargo throughput growth increasing to **3% YoY**. However, the overall trade environment remains cautious due to global economic conditions [32][32]. 7. **Inflation and Credit Growth**: - CPI is projected to rise to **0.9% YoY**, while PPI is expected to be less negative at **-2% YoY**. Total social financing (TSF) credit growth is anticipated to decline to **8.4% YoY** [34][33]. Additional Important Insights - **Structural Reforms**: The CEWC is expected to emphasize structural reforms, particularly in technology and social welfare, aiming to enhance the social safety net and income distribution [9]. - **Household Consumption Support**: There is a strong focus on boosting household consumption through both supply and demand-side measures, with potential for earlier subsidy disbursements in Q1 2026 [8]. - **Long-term Economic Outlook**: The overall economic outlook remains cautious, with expectations of continued challenges in the property sector and broader economic growth [10][10]. This summary encapsulates the key points discussed in the conference call, highlighting the current state and future expectations of the Chinese economy and its various sectors.
华泰证券梁红:创新已成为中国区别于其他经济体的一大特征
Xin Lang Cai Jing· 2025-12-07 08:54
专题:财经中国2025年会 12月7日,"和讯财经中国2025年会"在北京举行,主题为"寻找中国经济破局之路"。华泰证券机构业务 委员会主席梁红出席并演讲。 梁红表示,今年最显著的变化之一,是以DeepSeek为代表的技术突破,展现出中国在科技、消费等多 个领域的创新活力。 她指出,创新已成为中国区别于其他经济体的一大特征,这种趋势在资本市场中反映得尤为明显。"投 资者正在用信心投票,尤其是在那些代表未来方向的行业。" 专题:财经中国2025年会 12月7日,"和讯财经中国2025年会"在北京举行,主题为"寻找中国经济破局之路"。华泰证券机构业务 委员会主席梁红出席并演讲。 梁红提到,民营企业在"出海"与创新方面做出了重要尝试。中国产品正凭借其竞争力,从高端到中低端 全面进入全球市场,尤其在发展中国家市场中表现活跃。"当前出口的支撑,已不仅是价格优势,更多 是产品和技术的综合竞争力。"她强调,这种转变在今年复杂的国际环境下,展现出了令人意外的韧 性。 与此同时,梁红也提醒关注近期经济中出现的变化。她指出,尤其是十月以来,房地产与国内消费增速 出现下滑,这或将成为接下来需要重点应对的课题。在她看来,尽管中长期的 ...
周月亮:真理是“良知”在敞开状态下的涌现
Xin Lang Cai Jing· 2025-12-07 01:05
1.企业是横轴的,做产品,当把文化纵轴打开后,企业家就完成了自身升维,不再只是做物质产品,而 是出产思想产品。这就完成了从企业家到教育家的身份转变。 专题:2025《中国企业家》影响力企业家年会 第一性原理其实就是回到良知本身。 文|《中国企业家》记者 陈浩 编辑|马吉英 见习编辑|张昊 图片来源|中企图库 12月6~7日,由《中国企业家》杂志社主办的2025(第二十三届)影响力企业家年会(原中国企业领袖 年会),在北京召开。在5日进行的前沿大课环节,中国传媒大学阳明书院院长、著名传统文化学者周 月亮做了主题演讲。 以下为核心观点: 2.第一性原理其实就是回到良知本身,回到事情本身。真理不是死的,真理是活的,是良知和事情本身 在敞开状态下的涌现。 3.大家一定要立志当文化企业家。AI时代,人的意识是创新的动力。没有创新,人类就没有意义。 4.创新的点在哪里?在感性和理性电光火石相交时的那一下,可遇不可求。真正的创新是"不期而遇", 就是你回到真理、良知本来的状态,回到事情本来的状态。 以下为现场演讲实录(有删减): 现在AI有三派:一类是"驯鸟派",认为AI需要人来驯服、驯化,基于此出了一堆"训练哲学";一类 ...
阿联酋总统接见亚马逊创始人贝佐斯
Shang Wu Bu Wang Zhan· 2025-12-05 14:37
Core Viewpoint - The meeting between UAE President Mohammed and Amazon founder Jeff Bezos focused on collaboration in innovation, advanced technology, and artificial intelligence, particularly in education, healthcare, and economic sectors [1] Group 1: Collaboration and Innovation - Bezos praised the UAE's future vision and its strategy to leverage technology for societal development [1] - There is a willingness from Bezos to strengthen cooperation with the UAE in the innovation ecosystem [1]
外交部:中国愿向世界分享原创技术和创新场景,让创新成果更好造福全人类
Xin Hua She· 2025-12-05 12:05
Group 1 - The core viewpoint is that China is transitioning from being the "world's factory" to an "innovation powerhouse," emphasizing the importance of innovation in its economic and social development [1][2] - The term "innovation" is highlighted as a key focus in China's recent policy documents, with the "14th Five-Year Plan" mentioning it 61 times, reflecting its significance in national strategy [1] - China's global innovation index ranking has improved from 34th in 2012 to a projected 10th by 2025, indicating significant advancements in scientific and technological achievements [1] Group 2 - China's approach to innovation is characterized by openness and mutual benefit, aiming to share original technologies and innovation scenarios with the world [2] - Collaborative initiatives such as the involvement of 17 countries and 23 institutions in the Chinese space station project demonstrate China's commitment to international cooperation in scientific endeavors [2] - The establishment of the World Artificial Intelligence Cooperation Organization and the "AI+" international cooperation initiative reflects China's dedication to promoting inclusive and beneficial development in artificial intelligence [2]
中银国际:26年建议关注医疗服务板块的机会 看好医药板块创新、出海、消费三个方向
智通财经网· 2025-12-05 08:53
Core Viewpoint - The report from Zhongyin International indicates a significant divergence in the performance of various sub-sectors within the medical industry in 2025, with CXO and innovative drug-related sectors showing substantial growth. The firm remains optimistic about "product-driven" companies in 2026, as the industry trend continues to favor these companies, which are expected to gradually enter a profit cycle. Additionally, opportunities in the medical services sector are highlighted, despite its underwhelming performance in 2025, as the long-term logic of the sector remains intact and resilient [1][2]. Group 1: Sector Performance in 2025 - In 2025, the A-share market performed well, with all 31 Shenwan primary sectors recording positive returns by October 31, 2025. The pharmaceutical and biological sector ranked 10th with a growth rate of 34.95%. Among sub-sectors, CXO had the highest growth at 58.71%, followed by bioproducts at 57.59% and chemical preparations at 52.17%. In contrast, offline pharmacies and blood products had lower growth rates of 7.56% and 0.87%, respectively [1]. - As of October 31, 2025, the overall price-to-earnings (P/E) ratio for the pharmaceutical and biological sector was 30.82 times, indicating that the industry's valuation remains at a low level compared to 2020. The valuation increase in bioproducts and CXO is positively correlated with performance, while the valuation rise in vaccines and in vitro diagnostics is primarily due to profit declines [1]. Group 2: Outlook for Product-Driven Companies - The report emphasizes that "product-driven" companies are gradually overcoming the impacts of centralized procurement, with increased R&D investments leading to the launch of new products. Policy improvements, such as "anti-involution in centralized procurement" and "encouraging innovation," are guiding the pharmaceutical industry towards an innovation-driven transformation. This trend suggests that the industrial logic for "product-driven" companies will continue to be sustainable [2]. - The innovative drug sector is highlighted as a focal point, with the trend of innovative drug business development (BD) overseas gaining attention in 2025. This trend not only demonstrates the global competitiveness of Chinese innovative drugs but also serves as a crucial pathway for their international expansion. The performance of innovative drug companies and the clinical progress of key products are also noted as important areas to watch [2]. Group 3: Resilience of Medical Services - Despite a lackluster performance in 2025, the medical services sector is showing signs of gradual recovery, particularly in ophthalmology, where diagnostic and surgical volumes indicate a rebound. The long-term resilience of the medical services sector is supported by several factors: the increasing aging population leading to higher disease incidence, the exit of smaller companies due to centralized procurement and cost control, and the presence of unresolved issues in the industry, such as pathological myopia and glaucoma [3]. - The introduction of new technologies and products in the medical services sector presents significant growth opportunities. In 2026, the sector is expected to recover gradually, benefiting from the low base effect observed in 2025 [3].
潘刚引领伊利坚持“以消费者为中心”,以新供给引领新需求
Sou Hu Cai Jing· 2025-12-05 04:26
Core Insights - Yili Group reported a total revenue of 90.564 billion yuan for the first three quarters of 2025, marking a year-on-year growth of 1.71% [1] - The company's net profit attributable to shareholders exceeded 10 billion yuan for the first time, reaching 10.103 billion yuan, with a year-on-year increase of 18.73% [1] - Yili's chairman, Pan Gang, emphasized the importance of innovation for future growth, stating that the company is focused on new supply to meet new consumer demands [1] Financial Performance - Total revenue for the first three quarters: 90.564 billion yuan, up 1.71% year-on-year [1] - Net profit attributable to shareholders: 10.103 billion yuan, up 18.73% year-on-year [1] Innovation and Product Development - Yili launched several innovative products, including the "Jindian Fresh Pure Milk," which redefined the freshness boundary of ambient milk, receiving widespread market acclaim [1] - The company introduced a new sub-category of "light dairy juice drinks" with the product "Chew Lemon," which quickly gained popularity and refreshed the consumer experience [1] - Yili collaborated with Sam's Club to create "Raw Milk Green Bean Ice Cream," achieving a unique formulation with ≥35% raw milk and 19% green beans, winning the ice cream category championship [2] Awards and Recognition - Yili won two prestigious IDF Dairy Innovation Awards, becoming the most awarded dairy company globally and the only Chinese company to receive such recognition [2] - The "Xinhua Bone Health Formula Milk Powder," co-created with Beijing Tongrentang, won the "Human Nutrition Dairy Product Innovation Award" for addressing health concerns in China [2] - The "Anmuxi 'Only for a Bluer Sea'" limited edition eco-friendly packaging won the "Dairy Product Packaging and Transparency Innovation Award," providing a systematic green packaging solution for the industry [2] Strategic Focus - Yili adheres to the "consumer value leadership" philosophy, focusing on consumer needs and leveraging strategic determination to drive innovation and provide comprehensive nutritional solutions throughout the consumer lifecycle [4]
专访中国德国商会霍飞明:中国速度让人惊艳,两国应加强创新合作
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-04 10:30
南方财经21世纪经济报道记者郑青亭 北京报道 从追赶到并跑甚至部分引领,中国企业正在中德经济合作中展现出更自信的姿态。 "在全球范围内,中国是创新从概念到落地速度最快的市场之一,从研发、测试、实施到上市,整个周 期非常短。这种节奏反过来也改变了企业开展业务的方式,因为产品生命周期变得更短、创新链条更加 紧凑。"中国德国商会华北及东北地区董事会主席霍飞明博士 (MartinHofmann)对21世纪经济报道记 者说道。 12月2日,中国德国商会在北京举行《商业信心调查报告2025/2026》发布会。调查显示,56%的受访企 业正在考虑与中国合作伙伴展开更深入的合作,希望借助知识共享与品牌优势推动在华业务增长。霍飞 明在会后接受21世纪经济报道记者专访时表示,在华德企对"中国速度"有深刻的感触,希望深度参与中 国的创新生态,并将这种经验带回德国。"这也是为什么我们鼓励企业派人来中国学习创新速度背后的 逻辑。" 报告显示,60%的受访德企认为,中国同行企业在未来五年内将成为或已经成为其所在行业的创新领导 者,这一比例创下历史新高。值得关注的是,认为"中国同行企业已经是创新领导者"的比例从2019年的 0%升至202 ...
在从都,国际前政要们给了这些“关键词”|全球财经连线
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-04 08:25
Group 1 - The "2025 Chengdu International Forum" held in Guangzhou gathered over 200 guests, including more than 30 former heads of state and international organization leaders, highlighting China's global engagement [2][3] - Key terms reflecting perceptions of China's development included "Engineering," "Harmony," "Dynamic," "Innovation," and "China proposes and the rest of the world responds," indicating a positive international sentiment towards China's planning, social harmony, economic dynamism, and innovation [2][3][4] - Former Turkish EU Affairs Minister praised China for its significant role in maintaining global peace and stability, emphasizing China's international responsibilities [4]